ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,260Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 5176

$1.01M Total Retail Price of All Prescriptions

Rank: 260 out of 5176

618 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 15,239 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,218 1,029 1 2
METFORMIN HCL 1,028 874 2 7
SIMVASTATIN 1,012 889 3 1
HYDROCHLOROTHIAZIDE 977 834 4 10
METOPROLOL TARTRATE 852 752 5 6
CRESTOR 757 615 6 15
LOSARTAN POTASSIUM 560 486 7 14
GABAPENTIN 437 372 8 21
RAMIPRIL 436 313 9 50
TAMSULOSIN HCL 388 354 10 20
JANUVIA 376 310 11 25
ALENDRONATE SODIUM 353 323 12 18
LISINOPRIL 347 263 13 5
FOSINOPRIL SODIUM 343 310 14 105
ATENOLOL 340 294 15 12
NEXIUM 335 283 16 16
FUROSEMIDE 329 292 17 8
OMEPRAZOLE 320 276 18 3
FAMOTIDINE 297 202 19 58
LEVOTHYROXINE SODIUM 254 189 20 4
FLUTICASONE PROPIONATE 251 188 21 38
GLYBURIDE 241 193 R 22 67
ACTOS 221 184 23 85
GLIPIZIDE 217 188 24 63
HYDRALAZINE HCL 202 170 25 73
CLOPIDOGREL 167 138 26 26
ADVAIR DISKUS 165 137 27 32
TRAMADOL HCL 163 142 28 40
ALLOPURINOL 140 122 29 41
CARVEDILOL 139 86 30 24
PLAVIX 126 120 31 29
VENTOLIN HFA 123 105 32 64
ATORVASTATIN CALCIUM 120 92 33 9
LANTUS 105 86 34 66
PRAVASTATIN SODIUM 104 88 35 23
LANTUS SOLOSTAR 97 77 36 70
PIOGLITAZONE HCL 91 69 R 37 237
DIOVAN 91 80 37 19
SINGULAIR 91 79 37 62
SPIRONOLACTONE 90 66 40 88
DONEPEZIL HCL 84 84 41 28
FINASTERIDE 83 73 42 69
PRANDIN 80 64 43 150
INSULIN SYRINGE 79 67 44 137
NIASPAN 77 77 45 175
ZOLPIDEM TARTRATE 73 61 46 17
CALCITRIOL 72 59 47 261
RANITIDINE HCL 70 37 48 36
PEN NEEDLE 69 57 49 144
PROVENTIL HFA 68 56 50 226
SPIRIVA 66 60 51 54
CELEBREX 64 54 52 80
PROAIR HFA 62 42 53 60
METOPROLOL SUCCINATE 61 59 54 11
DILTIAZEM 24HR ER 60 48 55 136
ALCOHOL SWABS 59 50 56 115
METFORMIN HCL ER 57 55 57 57
GLIMEPIRIDE 57 45 57 37
ENALAPRIL MALEATE 57 32 57 22
OXYBUTYNIN CHLORIDE 55 49 60 227
MONTELUKAST SODIUM 55 42 60 123
LANSOPRAZOLE 53 47 62 113
ISOSORBIDE DINITRATE 52 52 63 288
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.